Clinical Trial Update: Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotavirus (RV) Vaccination

View source ↗

Summary

This completed study sponsored by GlaxoSmithKline analyzes the clinical and cost impact of complete versus incomplete rotavirus vaccination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infection

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Status: COMPLETED